Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study
Osteoporos Int
.
2017 Aug;28(8):2505.
doi: 10.1007/s00198-017-4105-1.
Authors
N C Wright
1
,
P J Foster
2
,
A S Mudano
2
,
J A Melnick
2
,
E M Lewiecki
3
,
W J Shergy
4
,
J R Curtis
2
,
G R Cutter
5
,
M I Danila
2
,
M L Kilgore
6
,
E C Lewis
7
,
S L Morgan
2
,
D T Redden
5
,
A H Warriner
8
,
K G Saag
2
Affiliations
1
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. ncwright@uab.edu.
2
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
3
New Mexico Clinical Research and Osteoporosis Center, Albuquerque, NM, USA.
4
Rheumatology Associates of North Alabama, Huntsville, AL, USA.
5
Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
6
Deparment of Health Care Organization and Policy, University of Alabama at Birmingham, Birmingham, AL, USA.
7
Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
8
Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, AL, USA.
PMID:
28593448
DOI:
10.1007/s00198-017-4105-1
No abstract available
Publication types
Published Erratum
Grants and funding
K23 AR062100/AR/NIAMS NIH HHS/United States
R21 AR062300/AR/NIAMS NIH HHS/United States